Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by skyhawk1on May 08, 2019 11:27am

143 Views

Post# 29724537

RE:RE:RE:RE:Anything to be excited about here?

Great insight & well read!

I TOTALLY AGREE 100% ~ Quattro!

Quattro74 wrote:
Fred, I think that shelf prospectus could also be explained positively. They may expect very good news, JV?, that will greatly boost sp. Once sp is up there they will have the shares to do a pp that will finance the company, other phase 1s, for many years. With minimal dilution.

fredgoodwinson wrote: Good summary Quattro - considering just how much they have advanced and how much they are de-risked the price is disappointing but this hokey-cokey with the shelf prospectus will not have inspired confidence.